Cutaneous antifungal agents : selected compounds in clinical practice and development
著者
書誌事項
Cutaneous antifungal agents : selected compounds in clinical practice and development
（Clinical dermatology, 7）
Dekker, c1993
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Provides practical information on the clinical use of leading antifungal agents, addressing their comparative efficacy, safety and patient acceptance. The chemistry, mode of action and in vitro and in vivo experimental results of antifungal drugs are discussed.
目次
- Introduction - antifungal therapy for cutaneous mycoses, John W. Rippon and Robert A. Fromtling
- morpholines - discovery and chemistry of amorolfine, Hans Peter Isenring, preclinical data of amorolfine, Annemarie Polak and Peter George Hartman, the action of amorolfine - from molecule to cell, Peter George Hartman and Annemarie Polak, safety of amorolfine in healthy volunteers and patients, Michael Zaug and Gaetano Roncati, clinical efficacy of amorolfine, Michael Zaug, clinical experiences with amorolfine, Amalia del Palicio
- allylamines - naftifine - in vitro and in vivo activities of naftifine, Hubert Mieth, biochemical mode of action of naftifine, Neil S. Ryder, clinical experience with naftifine, Matthias Brautigam and Gottfried Weidinger
- terbinafine - the discovery and chemistry of terbinafine, Anton Stutz, biochemical mode of action of terbinafine, Neil S. Ryder, in vitro and in vivo activities of terbinafine, Hubert Mieth, clinical use of oral and topical terbinafine in the treatment of fungal diseases, V.V. Villars and T.C. Jones
- fluconazole - the discovery of fluconazole, K. Richardson, chemistry and mode of action of fluconazole, C.A. Hitchcock and P.J. Whittle, in vitro and experimental in vivo activities of fluconazole against some fungi causing cutaneous mycoses, Peter F. Troke, safety of fluconazole, Ian H. Osterloh and Nigel D. Pluck, clinical efficacy of fluconazole in the treatment of cutaneous mycoses, Keith W. Brammer
- itraconazole - itraconazole - preclinical data in vitro and in vivo in cutaneous and other superficial mycoses, Frank C. Odds and Jan Van Cutsem, discovery, chemistry, mode of action, and selectivity of itraconazole, H. Vanden Bossche et al, safety of itraconazole in animals and humans, Ann Lampo et al, clinical efficacy of itraconazole - focus on cutaneous infections, Geert Cauwenbergh, clinical experience with itraconazole, E.L. Svejgaard
- compounds in development - the nikkomycins - an overview of nikkomycins - history, biochemistry, and applications, Hans Peter Fiedler et al, the use of nikkomycin Z singly and in combination with azoles for infections caused by Candida, Richard F. Hector, interactions between chitin and beta glucan synthesis inhibitors - a new approach to antifungal development for cutaneous infections, John R. Perfect
- the pneumocandins - discovery, production process development, and isolation of pneumocandin B[0], Robert E. Schwartz et al, chemical and structure-activity studies of the echinocandin lipopeptides, Milton L. Hammond, biological activity of the pneumocandins, Ken Bartizal et al.
「Nielsen BookData」 より